MECVX
Price
$15.50
Change
-$0.09 (-0.58%)
Updated
Aug 5 closing price
Net Assets
146.64M
RNPHX
Price
$69.28
Change
-$0.56 (-0.80%)
Updated
Aug 5 closing price
Net Assets
156.68B
Interact to see
Advertisement

MECVX vs RNPHX

Header iconMECVX vs RNPHX Comparison
Open Charts MECVX vs RNPHXBanner chart's image
NYLI Epoch Capital Growth Investor Class
Price$15.50
Change-$0.09 (-0.58%)
VolumeN/A
Net Assets146.64M
American Funds New Perspective R5E
Price$69.28
Change-$0.56 (-0.80%)
VolumeN/A
Net Assets156.68B
MECVX vs RNPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MECVX vs. RNPHX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MECVX is a StrongBuy and RNPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 157B vs. MECVX (147M). RNPHX pays higher dividends than MECVX: RNPHX (0.66) vs MECVX (0.10). MECVX was incepted earlier than RNPHX: MECVX (9 years) vs RNPHX (10 years). MECVX (1.41) is less costly to investors than RNPHX (0.56). MECVX is a more actively managed with annual turnover of: 33.00 vs. RNPHX (24.00). RNPHX has a lower initial minimum investment than MECVX: RNPHX (250) vs MECVX (2500). RNPHX annual gain was more profitable for investors over the last year : 19.20 vs. MECVX (9.03). RNPHX return over 5 years is better than : 35.75 vs. MECVX (6.31).
MECVXRNPHXMECVX / RNPHX
Total Expense Ratio1.410.56252%
Annual Report Gross Expense Ratio1.410.56252%
Fund Existence9 years10 years-
Gain YTD5.65812.76044%
Front Load5%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets147M157B0%
Annual Yield % from dividends0.100.6615%
Returns for 1 year9.0319.2047%
Returns for 3 years39.5835.75111%
Returns for 5 years6.3135.7518%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMUEX13.58N/A
N/A
GMO US Equity III
BPSCX24.60N/A
N/A
Boston Partners Small Cap Value II Inv
HEMCX9.97N/A
N/A
Janus Henderson Emerging Markets C
TRSCX29.87N/A
N/A
Nuveen Large Cap Responsible Eq Ret
SFSNX17.60N/A
N/A
Schwab Fundamental US Small Company Idx